Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris (2011-00500-15)

This study has been completed.
Information provided by (Responsible Party):
Delenex Therapeutics AG Identifier:
First received: May 9, 2012
Last updated: January 7, 2013
Last verified: January 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2012
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)